| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advances in vaccinia virus-based vaccine vectors, with applications in flavivirus vaccine development
|
Xie, Lilan
|
|
|
40 |
49 |
p. 7022-7031
|
artikel
|
| 2 |
An observational, cohort, multi-centre, open label phase IV extension study comparing preschool DTAP-IPV booster vaccine responses in children whose mothers were randomised to one of two pertussis-containing vaccines or received no pertussis-containing vaccine in pregnancy in England
|
Sapuan, Shari
|
|
|
40 |
49 |
p. 7050-7056
|
artikel
|
| 3 |
An Oil-in-Water adjuvant significantly increased influenza A/H7N9 split virus Vaccine-Induced circulating follicular helper T (cTFH) cells and antibody responses
|
Lai, Lilin
|
|
|
40 |
49 |
p. 7065-7072
|
artikel
|
| 4 |
A queueing Network approach for capacity planning and patient Scheduling: A case study for the COVID-19 vaccination process in Colombia
|
Franco, Carlos
|
|
|
40 |
49 |
p. 7073-7086
|
artikel
|
| 5 |
A retrospective evaluation of side‐effects associated with the booster dose of Pfizer-BioNTech/BNT162b2 COVID‐19 vaccine among females in Eastern Province, Saudi Arabia
|
Hassan, Yousif A.M.
|
|
|
40 |
49 |
p. 7087-7096
|
artikel
|
| 6 |
Association of parent influenza vaccination and early childhood vaccinations using linked electronic health record data
|
Kaufmann, Jorge
|
|
|
40 |
49 |
p. 7097-7107
|
artikel
|
| 7 |
Clinical trial and postmarketing safety experience with MenACWY-TT, a meningococcal group A, C, W, and Y tetanus conjugate vaccine
|
Serra, Lidia
|
|
|
40 |
49 |
p. 7014-7021
|
artikel
|
| 8 |
Cost-effectiveness analyses of 15- and 20-valent pneumococcal conjugate vaccines for Japanese elderly
|
Hoshi, Shu-ling
|
|
|
40 |
49 |
p. 7057-7064
|
artikel
|
| 9 |
Developing communication tools on rotavirus vaccination to support family paediatricians in Italy
|
Marchetti, Federico
|
|
|
40 |
49 |
p. 7108-7114
|
artikel
|
| 10 |
Editorial Board/Aims and Scope
|
|
|
|
40 |
49 |
p. IFC
|
artikel
|
| 11 |
Identifying COVID-19 optimal vaccine dose using mathematical immunostimulation/immunodynamic modelling
|
Rhodes, Sophie
|
|
|
40 |
49 |
p. 7032-7041
|
artikel
|
| 12 |
Identifying early adopters of COVID-19 vaccines in Latin America
|
Arrieta, Alejandro
|
|
|
40 |
49 |
p. 7158-7166
|
artikel
|
| 13 |
Measuring the impact of COVID-19 vaccination and immunity waning: A modelling study for Portugal
|
Caetano, Constantino
|
|
|
40 |
49 |
p. 7115-7121
|
artikel
|
| 14 |
Moral injury in health care: A focus on immunization
|
Ricciardelli, Rosemary
|
|
|
40 |
49 |
p. 7011-7013
|
artikel
|
| 15 |
Opinions, attitudes, and barriers to pediatric vaccination in Argentina
|
Urueña, A.
|
|
|
40 |
49 |
p. 7042-7049
|
artikel
|
| 16 |
Optimal Respiratory Syncytial Virus intervention programmes using Nirsevimab in England and Wales
|
Hodgson, David
|
|
|
40 |
49 |
p. 7151-7157
|
artikel
|
| 17 |
Pertussis, diphtheria, and tetanus antibodies seroprevalence in pregnant women and neonates, as a preliminary data for introduction of preconception or prenatal DTaP vaccination among Japanese society
|
Tsurane, Kotoi
|
|
|
40 |
49 |
p. 7122-7129
|
artikel
|
| 18 |
Safety, tolerability and immunogenicity of Biological E’s CORBEVAX™ vaccine in children and adolescents: A prospective, randomised, double-blind, placebo controlled, phase-2/3 study
|
Thuluva, Subhash
|
|
|
40 |
49 |
p. 7130-7140
|
artikel
|
| 19 |
The resurgence risk of COVID-19 in China in the presence of immunity waning and ADE: A mathematical modelling study
|
Zhou, Weike
|
|
|
40 |
49 |
p. 7141-7150
|
artikel
|
Tijdschrift beschrijving